CORRECTED-UPDATE 2-Novartis sickle-cell drug gets U.S. FDA approval

16 Nov 2019

Novartis AG on Friday won U.S.
approval for its experimental sickle cell disease drug, Adakveo,
making it the first of several proposed new therapies designed
to offer lasting relief for patients with the debilitating blood
disease to get U.S. regulatory clearance.

Read full article at Reuters